EDGAR Filing Documents for 0001047469-17-003483

Form S-4/A - Registration of securities, business combinations: [Amend]

SEC Accession No. 0001047469-17-003483

Filing Date

2017-05-18

Accepted

2017-05-18 16:47:07

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-4/A	a2232194zs-4a.htm	S-4/A	864952
2	EX-5.1	a2232194zex-5_1.htm	EX-5.1	58223
3	EX-8.1	a2232194zex-8_1.htm	EX-8.1	27516
4	EX-23.1	a2232194zex-23_1.htm	EX-23.1	3041
5	EX-99.1	a2232194zex-99_1.htm	EX-99.1	87237
6	EX-99.2	a2232194zex-99_2.htm	EX-99.2	12315
7	EX-99.3	a2232194zex-99_3.htm	EX-99.3	10697
8	EX-99.4	a2232194zex-99_4.htm	EX-99.4	11094
9	EX-99.5	a2232194zex-99_5.htm	EX-99.5	13916
10	EX-99.6	a2232194zex-99_6.htm	EX-99.6	18266
11	EX-99.7	a2232194zex-99_7.htm	EX-99.7	33311
12	G1130011LAI001.JPG	g1130011lai001.jpg	GRAPHIC	4038
13	G44098.JPG	g44098.jpg	GRAPHIC	8336
14	G922024.JPG	g922024.jpg	GRAPHIC	33092
15	G4873.JPG	g4873.jpg	GRAPHIC	25393
	Complete submission text file	0001047469-17-003483.txt		1239791

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406

Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 6108166640

Nabriva Therapeutics Plc (Filer) CIK: 0001703287 (see all company filings)